Europe Injectable Drug Delivery Market Poised to Grow At 11.9% till 2024

According to Data Bridge Market Research new market report “Europe Injectable Drug Delivery Market By Type {Devices (Conventional, Self),  Formulations (Conventional, Noble, Long Acting)} Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology) Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System) End User (Hospitals, Clinics, Home Care Settings, Research Laboratories) Country (Germany, France, U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherlands, and Rest of Europe) – Industry Trends and Forecast to 2024”

Europe Regional Snapshot

Access Full Report : http://databridgemarketresearch.com/reports/europe-injectable-drug-delivery-market/

Europe injectable drug delivery market is estimated at USD 107.4 billion in 2016 and is projected to reach USD 265.0 billion by 2024, at a CAGR of 11.9% during the forecast period from 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Market Segmentation: Europe Injectable Drug Delivery Market

  • The Europe injectable drug delivery market is segmented based on type, applications, usage pattern, mode of administration, end-user, and geography.
  • Based on type, the europe injectable drug delivery market is segmented into devices and formulations.
  • By product, the needle free injectors are further segmented into fillable needle-free injectors and prefilled needle-free injectors.
  • On the basis of applications, the Europe injectable drug delivery market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others.
  • Based on indications, the europe injectable drug delivery market is segmented into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis, and others.
  • Based on mode of administration, the europe injectable drug delivery market is segmented into skin, circulatory, organs, and central nervous system.
  • On the basis of usage pattern, the market is segmented into curative care, immunization, and others.
  • On the basis of end user, the market is segmented into hospitals, clinics, home care settings, research laboratories, and pharma and biotech companies.

Geographical Segmentation: Europe Injectable Drug Delivery Market

Based on geography, the europe injectable drug delivery market is segmented into 11 major countries such as Germany, France, U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherlands, and Rest of Europe.

Competitive Landscape: Europe Injectable Drug Delivery Market

The market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market.

Some of the major players operating in this market are :

  • Baxter International, Inc.
  • Becton
  • Dickinson and Company
  • Gerresheimer AG
  • Pfizer, Inc.
  • Schott AG
  • Alkermes Plc.
  • Eli Lilly and Company
  • Sandoz
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd
  • Among others.

Browse Related Reports:

North America Injectable Drug Delivery Market By Type {Devices (Conventional, Self), Formulations (Conventional, Noble, Long Acting Injection)} Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology); Usage Pattern (Curative Care, Immunizations, Other Usage Patterns) Mode of Administration (Skin, Circulatory, Organs, Central Nervous System) End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies) Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/north-america-injectable-drug-delivery-market/

APAC  Injectable Drug Delivery Market By Type {Devices (Conventional, Self),  Formulations (Conventional, Noble, Long Acting)} Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology) Usage Pattern (Curative Care, Immunizations,) Mode of Administration (Skin, Circulatory, Organs, Central Nervous System) End User (Hospitals, Clinics, Home Care Settings, Research Laboratories) Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of APAC) – Industry Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/asia-pacific-injectable-drug-delivery-market/